<document id="DDI-DrugBank.d497">
    <sentence id="DDI-DrugBank.d497.s2" text="However, in patients treated with oral carbonic anhydrase inhibitors, rare instances of drug interactions have occurred with high-dose salicylate therapy.">
        <entity charOffset="39-67" id="DDI-DrugBank.d497.s2.e0" text="carbonic anhydrase inhibitors" type="group" />
        <entity charOffset="135-144" id="DDI-DrugBank.d497.s2.e1" text="salicylate" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d497.s2.e0" e2="DDI-DrugBank.d497.s2.e1" id="DDI-DrugBank.d497.s2.p0" type="int" />
    </sentence>
    <sentence id="DDI-DrugBank.d497.s3" text="Therefore, the potential for such drug interaction should be considered in patients receiving AZOPT (brinzolamide ophthalmic suspension) 1%.">
        <entity charOffset="94-98" id="DDI-DrugBank.d497.s3.e0" text="AZOPT" type="brand" />
        <entity charOffset="101-112" id="DDI-DrugBank.d497.s3.e1" text="brinzolamide" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d497.s3.e0" e2="DDI-DrugBank.d497.s3.e1" id="DDI-DrugBank.d497.s3.p0" />
    </sentence>
</document>